acetazolamide has been researched along with Cerebrovascular Disorders in 119 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acetazolamide (ACZ) was applied to brain SPECT to evaluate the vascular reserve, and ACZ stress brain imaging was useful for predicting perioperative cerebrovascular events." | 5.30 | Combined thallium-201 myocardial with technetium-99m-HMPAO brain SPECT: myocardial ischemia induced by acetazolamide in severe coronary artery disease. ( Hayashida, K; Hirose, Y; Kume, N; Nishimura, T; Shimotsu, Y, 1998) |
| "36 patients with unilateral, hemodynamically significant carotid stenosis were investigated using transcranial Doppler acetazolamide-test." | 5.08 | [Assessment of cerebrovascular reactivity in patients with symptomatic and asymptomatic atherosclerotic carotid artery lesions]. ( Csiba, L; Dink, L; Fülesdi, B; Káposzta, Z; Limburg, M; Oláh, L; Orosz, L; Valikovics, A, 1998) |
| " The ratio of cerebral blood volume to cerebral blood flow (CBV/CBF) and vasoreactivity in response to hypercapnia (%CBF(hypercapnia)) and acetazolamide (ACZ) stress (%CBF(ACZ)) were measured to evaluate circulatory reserve." | 3.73 | Relationship between cerebral circulatory reserve and oxygen extraction fraction in patients with major cerebral artery occlusive disease: a positron emission tomography study. ( Hatazawa, J; Moroi, J; Nagata, K; Sato, M; Shimosegawa, E; Suzuki, A; Yata, K, 2006) |
| "Three normal volunteers and 12 patients with an obstruction of major cerebral arteries underwent PET measurements of the CBF after an injection of H2(15)O: (1) in the resting condition, (2) during hyperventilation (HV scan), (3) 1 to 3 minutes after hyperventilation (post-HV scan), (4) during the inhalation of 5% CO2, and (5) after an injection of acetazolamide." | 3.70 | Posthyperventilatory steal response in chronic cerebral hemodynamic stress: a positron emission tomography study. ( Hirakawa, K; Ishii, K; Matsushima, Y; Nariai, T; Senda, M; Toyama, H; Wakabayashi, S; Yokota, T, 1998) |
| " Patients should be informed of such adverse effects of intravenous acetazolamide administration prior to the acetazolamide challenge test for evaluation of cerebrovascular reactivity." | 2.76 | Adverse effects of intravenous acetazolamide administration for evaluation of cerebrovascular reactivity using brain perfusion single-photon emission computed tomography in patients with major cerebral artery steno-occlusive diseases. ( Kobayashi, M; Kubo, Y; Kuroda, H; Ogasawara, K; Ogawa, A; Saito, H; Suzuki, T; Yoshida, K, 2011) |
| "In 53 patients with chronic occlusive cerebrovascular diseases, we evaluated cerebral perfusion reserve." | 2.68 | [SPECT evaluation of cerebral perfusion reserve in patients with occlusive cerebrovascular diseases: evaluation with acetazolamide test and crossed cerebellar diaschisis]. ( Sugawara, Y, 1995) |
| "In 14 patients with cerebrovascular diseases, the corrected rCBFs correlated well with those by 133Xe gas inhalation method with the improvement of the slope of regression line (0." | 1.30 | [Regional cerebral blood flow measurements at pre- and post-Diamox test using split dose 99mTc-ECD SPECT: comparison with 133Xe inhalation method and linearization correction]. ( Sogabe, I, 1997) |
| "Acetazolamide (ACZ) was applied to brain SPECT to evaluate the vascular reserve, and ACZ stress brain imaging was useful for predicting perioperative cerebrovascular events." | 1.30 | Combined thallium-201 myocardial with technetium-99m-HMPAO brain SPECT: myocardial ischemia induced by acetazolamide in severe coronary artery disease. ( Hayashida, K; Hirose, Y; Kume, N; Nishimura, T; Shimotsu, Y, 1998) |
| "Acetazolamide c hallenge was assumed to result in an average increase in flow of 40% in the cerebellum." | 1.30 | Use of 123I-IMP brain SPET to predict outcome following STA-MCA bypass surgery: cerebral blood flow but not vasoreactivity is a predictive parameter. ( Cho, I; Hayashida, K; Iwama, T; Kume, N; Matsunaga, N, 1998) |
| "The acetazolamide-induced increase of cerebral blood flow could be reliably monitored by increase of cerebral 99mTc-HMPAO uptake, which varied between 11." | 1.28 | 99mTc-HMPAO-SPECT with acetazolamide challenge to detect hemodynamic compromise in occlusive cerebrovascular disease. ( Fuchs, C; Knop, J; Siepmann, G; Thie, A; Zeumer, H, 1992) |
| "At rest the patients with cerebral infarction, irrespective of whether ICa stenosis-occlusion was present or not, showed abnormal side-to-side CBF asymmetry." | 1.28 | CBF side-to-side asymmetries in stenosis-occlusion of internal carotid artery. Relevance of CT findings and collateral supply. ( Cavestri, R; D'Angelo, V; Ferrarini, F; Longhini, E; Nobili, F; Radice, L; Rodriguez, G; Sgorbati, C, 1991) |
| "The xenon CT method is an asset in the diagnosis of cerebral diseases since it provides information on functional changes in addition to the morphological findings." | 1.28 | [Non-invasive measurement of cerebrovascular circulation using xenon(s) computerized tomography. A review]. ( Nabi Nemati, M, 1990) |
| "Experimental vasogenic cerebral edema was created in rabbits with a cold-induced left occipital cortical lesions." | 1.26 | Acute therapeutic modalities for experimental vasogenic edema. ( Harbaugh, RD; James, HE; Laurin, R; Marshall, LF; Shapiro, HM, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (11.76) | 18.7374 |
| 1990's | 62 (52.10) | 18.2507 |
| 2000's | 25 (21.01) | 29.6817 |
| 2010's | 15 (12.61) | 24.3611 |
| 2020's | 3 (2.52) | 2.80 |
| Authors | Studies |
|---|---|
| Murai, S | 1 |
| Sugiu, K | 1 |
| Hishikawa, T | 1 |
| Hiramatsu, M | 1 |
| Nishihiro, S | 1 |
| Kidani, N | 1 |
| Takahashi, Y | 2 |
| Nishi, K | 1 |
| Yamaoka, Y | 1 |
| Date, I | 1 |
| Callen, AL | 1 |
| Dupont, SM | 1 |
| Pyne, J | 1 |
| Talbott, J | 1 |
| Tien, P | 1 |
| Calabrese, E | 1 |
| Saloner, D | 1 |
| Chow, FC | 1 |
| Narvid, J | 1 |
| Kakuta, K | 1 |
| Asano, K | 1 |
| Katayama, K | 1 |
| Ohkuma, H | 1 |
| Fleischer, CC | 1 |
| Wu, J | 3 |
| Qiu, D | 3 |
| Park, SE | 1 |
| Nahab, F | 3 |
| Dehkharghani, S | 3 |
| Misaki, K | 1 |
| Uchiyama, N | 1 |
| Inaki, A | 1 |
| Kinuya, S | 2 |
| Nambu, I | 1 |
| Kamide, T | 1 |
| Mohri, M | 1 |
| Hayashi, Y | 1 |
| Nakada, M | 1 |
| Hartkamp, NS | 2 |
| Hendrikse, J | 3 |
| de Borst, GJ | 2 |
| Kappelle, LJ | 1 |
| Bokkers, RPH | 1 |
| Siero, JC | 1 |
| Donahue, MJ | 1 |
| Harteveld, AA | 1 |
| Compter, A | 1 |
| Petersen, ET | 1 |
| Haga, S | 1 |
| Morioka, T | 1 |
| Shimogawa, T | 1 |
| Akiyama, T | 1 |
| Murao, K | 1 |
| Kanazawa, Y | 1 |
| Sayama, T | 1 |
| Arakawa, S | 1 |
| Schytz, HW | 1 |
| Yoshie, T | 1 |
| Ueda, T | 1 |
| Takada, T | 1 |
| Nogoshi, S | 1 |
| Fukano, T | 1 |
| Hasegawa, Y | 3 |
| Yoshida, J | 2 |
| Ogasawara, K | 2 |
| Chida, K | 1 |
| Oikawa, K | 1 |
| Matsumoto, Y | 1 |
| Nomura, J | 1 |
| Ogasawara, Y | 1 |
| Fujiwara, S | 1 |
| Kobayashi, M | 3 |
| Yoshida, K | 2 |
| Terasaki, K | 1 |
| Ogawa, A | 2 |
| Allen, J | 1 |
| Inoue, N | 1 |
| Harada, M | 1 |
| Yoshimura, S | 2 |
| Kitajima, H | 1 |
| Enomoto, Y | 1 |
| Yamada, K | 2 |
| Iwama, T | 3 |
| Bokkers, RP | 1 |
| van Osch, MJ | 1 |
| van der Worp, HB | 1 |
| Mali, WP | 1 |
| Iida, H | 2 |
| Nakagawara, J | 2 |
| Hayashida, K | 4 |
| Fukushima, K | 1 |
| Watabe, H | 1 |
| Koshino, K | 1 |
| Zeniya, T | 1 |
| Eberl, S | 1 |
| Saito, H | 1 |
| Suzuki, T | 1 |
| Kuroda, H | 1 |
| Kubo, Y | 1 |
| Farid, K | 1 |
| Petras, S | 1 |
| Ducasse, V | 1 |
| Chokron, S | 1 |
| Helft, G | 1 |
| Blacher, J | 1 |
| Caillat-Vigneron, N | 1 |
| Inoue, T | 1 |
| Fujimura, M | 1 |
| Shimizu, H | 1 |
| Tominaga, T | 1 |
| Miyazaki, Y | 1 |
| Hashimoto, M | 1 |
| Murata, Y | 1 |
| Inoue, H | 1 |
| Shiozaki, J | 1 |
| Takimoto, M | 1 |
| Yoshioka, K | 1 |
| Nakajima, K | 1 |
| Taki, J | 1 |
| Nishizawa, S | 2 |
| Tsuchida, T | 2 |
| Ito, H | 2 |
| Konishi, J | 5 |
| Yonekura, Y | 6 |
| Okazawa, H | 5 |
| Yamauchi, H | 2 |
| Sugimoto, K | 2 |
| Takahashi, M | 1 |
| FAZEKAS, JF | 2 |
| ALMAN, RW | 2 |
| TICKTIN, HE | 1 |
| EHRMANTRAUT, WR | 1 |
| SAVARESE, CJ | 1 |
| Settakis, G | 1 |
| Molnár, C | 2 |
| Kerényi, L | 1 |
| Kollár, J | 1 |
| Legemate, D | 1 |
| Csiba, L | 3 |
| Fülesdi, B | 3 |
| Toyoda, H | 1 |
| Fujibayashi, Y | 1 |
| Bass, A | 1 |
| Takeuchi, R | 3 |
| Nagaki, A | 1 |
| Kobara, K | 1 |
| Matsutomo, N | 1 |
| Ritland, JS | 1 |
| Egge, K | 1 |
| Lydersen, S | 1 |
| Juul, R | 1 |
| Semb, SO | 1 |
| Kaku, Y | 1 |
| Kokuzawa, J | 1 |
| Chazova, IE | 1 |
| Mychka, VB | 1 |
| Gornostaev, VV | 1 |
| Dvoskina, IM | 1 |
| Sergienko, VB | 1 |
| Shidahara, M | 1 |
| Inoue, K | 1 |
| Goto, R | 1 |
| Kinomura, S | 1 |
| Taki, Y | 1 |
| Okada, K | 1 |
| Kaneta, T | 1 |
| Sato, K | 3 |
| Sato, T | 1 |
| Fukuda, H | 1 |
| Yata, K | 1 |
| Suzuki, A | 1 |
| Hatazawa, J | 1 |
| Shimosegawa, E | 1 |
| Nagata, K | 1 |
| Sato, M | 1 |
| Moroi, J | 1 |
| Gurevich, T | 1 |
| Gur, AY | 2 |
| Bornstein, NM | 2 |
| Giladi, N | 1 |
| Korczyn, AD | 1 |
| Shiogai, T | 1 |
| Morisaka, A | 1 |
| Takayasu, N | 1 |
| Yoshikawa, K | 1 |
| Mizuno, T | 1 |
| Nakagawa, M | 1 |
| Furuhata, H | 1 |
| Arai, Y | 1 |
| Pagani, M | 1 |
| Isozaki, M | 1 |
| Chen, A | 1 |
| Shyr, MH | 1 |
| Chen, TY | 1 |
| Lai, HY | 1 |
| Lin, CC | 1 |
| Yen, PS | 1 |
| Schneider, UC | 1 |
| Schilling, L | 1 |
| Schroeck, H | 1 |
| Nebe, CT | 1 |
| Vajkoczy, P | 1 |
| Woitzik, J | 1 |
| Smith, LM | 1 |
| Elkins, JS | 1 |
| Dillon, WP | 1 |
| Schaeffer, S | 1 |
| Wintermark, M | 1 |
| Kuwabara, Y | 3 |
| Ichiya, Y | 3 |
| Sasaki, M | 3 |
| Yoshida, T | 3 |
| Masuda, K | 3 |
| Okudaira, Y | 2 |
| Bandoh, K | 1 |
| Arai, H | 2 |
| Sugawara, Y | 1 |
| Inoue, Y | 1 |
| Momose, T | 1 |
| Machida, K | 1 |
| Honda, N | 1 |
| Mamiya, T | 1 |
| Takahashi, T | 1 |
| Tsutsumi, K | 1 |
| Tanaka, F | 2 |
| Fujita, T | 2 |
| Tsuchimochi, S | 1 |
| Ishizu, K | 2 |
| Tamaki, N | 2 |
| Webster, MW | 1 |
| Makaroun, MS | 1 |
| Steed, DL | 1 |
| Smith, HA | 3 |
| Johnson, DW | 4 |
| Yonas, H | 6 |
| Pávics, L | 3 |
| Grünwald, F | 1 |
| Barzó, P | 3 |
| Ambrus, E | 2 |
| Menzel, C | 1 |
| Schomburg, A | 1 |
| Borda, L | 2 |
| Máté, E | 1 |
| Bodosi, M | 2 |
| Csernay, L | 2 |
| Leinsinger, G | 1 |
| Piepgras, A | 2 |
| Einhäupl, K | 1 |
| Schmiedek, P | 2 |
| Kirsch, CM | 1 |
| Thompson-Dobkin, J | 1 |
| Flint, E | 1 |
| Mathews, D | 1 |
| Walker, BS | 1 |
| Allen, BC | 1 |
| Batjer, H | 1 |
| Purdy, PD | 1 |
| Akashi, Y | 1 |
| Fukumura, T | 2 |
| Isaka, Y | 1 |
| Iiji, O | 1 |
| Okamoto, M | 1 |
| Imaizumi, M | 1 |
| Ashida, K | 1 |
| Nakamura, J | 1 |
| Takeda, R | 1 |
| Okumura, T | 1 |
| Seki, T | 1 |
| Hayase, K | 1 |
| Satoh, K | 1 |
| Suematsu, K | 1 |
| Machac, J | 1 |
| Vallabhajosula, S | 1 |
| Haubitz, B | 2 |
| Holl, K | 2 |
| Becker, H | 2 |
| Durham, SR | 1 |
| Pentheny, SL | 1 |
| Chamorro, A | 1 |
| Saiz, A | 1 |
| Vila, N | 1 |
| Ascaso, C | 1 |
| Blanc, R | 1 |
| Alday, M | 1 |
| Pujol, J | 1 |
| Gückel, F | 1 |
| Brix, G | 1 |
| Rempp, K | 1 |
| Köpke, J | 1 |
| Lämmler, B | 1 |
| Georgi, M | 1 |
| Yamamoto, N | 1 |
| Nariai, T | 2 |
| Patrick, JT | 1 |
| Fritz, JV | 1 |
| Adamo, JM | 1 |
| Dandonna, P | 1 |
| Ohnishi, T | 2 |
| Nakano, S | 2 |
| Yano, T | 2 |
| Hoshi, H | 1 |
| Jinnouchi, S | 2 |
| Nagamachi, S | 2 |
| Flores, L | 1 |
| Watanabe, K | 2 |
| Yokogami, K | 1 |
| Ohta, H | 1 |
| Hirano, T | 1 |
| Minematsu, K | 2 |
| Yamaguchi, T | 3 |
| Wong, CO | 1 |
| MacIntyre, WJ | 1 |
| Chen, EQ | 1 |
| Saha, GB | 1 |
| Chyatte, D | 1 |
| Go, RT | 1 |
| Pindzola, RP | 1 |
| Limburg, M | 2 |
| Neuwirth, G | 1 |
| Valikovics, A | 2 |
| Bova, I | 1 |
| Hattori, N | 1 |
| Wang, J | 1 |
| Matsuda, H | 4 |
| Sakahara, H | 1 |
| Tanaka, Y | 1 |
| Hirose, Y | 2 |
| Kume, N | 3 |
| Miyake, Y | 2 |
| Ishida, Y | 1 |
| Matsuura, H | 1 |
| Nishimura, T | 2 |
| Sogabe, I | 1 |
| Gambhir, S | 1 |
| Inao, S | 1 |
| Tadokoro, M | 1 |
| Nishino, M | 1 |
| Ito, K | 1 |
| Ishigaki, T | 1 |
| Kuchiwaki, H | 1 |
| Flores, LI | 1 |
| Nakahara, H | 1 |
| Itoh, S | 1 |
| Iwata, A | 1 |
| Watanabe, Y | 1 |
| Kitano, S | 1 |
| Imai, S | 1 |
| Yoshiya, K | 1 |
| Yokota, C | 1 |
| Shimotsu, Y | 1 |
| Orosz, L | 1 |
| Oláh, L | 1 |
| Dink, L | 1 |
| Káposzta, Z | 1 |
| Odano, I | 1 |
| Ohkubo, M | 1 |
| Noguchi, E | 1 |
| Ohtaki, H | 1 |
| Shibaki, M | 1 |
| Dobashi, S | 1 |
| Pindzola, RR | 1 |
| Meltzer, CC | 1 |
| Sasser, H | 1 |
| Fujii, K | 1 |
| Fukui, M | 1 |
| Senda, M | 1 |
| Ishii, K | 1 |
| Wakabayashi, S | 1 |
| Yokota, T | 1 |
| Toyama, H | 1 |
| Matsushima, Y | 1 |
| Hirakawa, K | 1 |
| Cho, I | 1 |
| Matsunaga, N | 1 |
| Arigoni, M | 1 |
| Kneifel, S | 1 |
| Fandino, J | 1 |
| Khan, N | 1 |
| Burger, C | 1 |
| Buck, A | 1 |
| Nakanishi, H | 1 |
| Vander Borght, T | 1 |
| Laloux, P | 1 |
| Maes, A | 1 |
| Salmon, E | 1 |
| Goethals, I | 1 |
| Goldman, S | 1 |
| Harbaugh, RD | 1 |
| James, HE | 1 |
| Marshall, LF | 1 |
| Shapiro, HM | 1 |
| Laurin, R | 1 |
| Dóczi, T | 1 |
| Katona, E | 2 |
| Morvay, Z | 1 |
| Devous, MD | 2 |
| Payne, JK | 1 |
| Lowe, JL | 1 |
| Knop, J | 1 |
| Thie, A | 1 |
| Fuchs, C | 1 |
| Siepmann, G | 1 |
| Zeumer, H | 1 |
| Araki, Y | 1 |
| Tanaka, H | 1 |
| Ohtani, M | 1 |
| Yamamoto, H | 1 |
| Yamamoto, T | 1 |
| Tsukaguchi, I | 1 |
| Cikrit, DF | 2 |
| Burt, RW | 4 |
| Dalsing, MC | 1 |
| Lalka, SG | 1 |
| Sawchuk, AP | 1 |
| Waymire, B | 1 |
| Witt, RM | 3 |
| Tsuji, S | 2 |
| Sumiya, H | 2 |
| Hogashi, S | 1 |
| Kinuya, K | 2 |
| Tonami, N | 1 |
| Hisada, K | 2 |
| Yamashita, J | 2 |
| Smeda, JS | 1 |
| Tkachenko, O | 1 |
| Touho, H | 1 |
| Karasawa, J | 1 |
| Shishido, H | 1 |
| Morisako, T | 1 |
| Shibamoto, K | 1 |
| Ringelstein, EB | 1 |
| Van Eyck, S | 1 |
| Mertens, I | 1 |
| Dahl, A | 1 |
| Lindegaard, KF | 1 |
| Russell, D | 1 |
| Nyberg-Hansen, R | 1 |
| Rootwelt, K | 1 |
| Sorteberg, W | 1 |
| Nornes, H | 1 |
| Reddy, RV | 2 |
| Cavestri, R | 1 |
| Radice, L | 1 |
| Ferrarini, F | 1 |
| Sgorbati, C | 1 |
| D'Angelo, V | 1 |
| Rodriguez, G | 1 |
| Nobili, F | 1 |
| Longhini, E | 1 |
| Yudd, AP | 1 |
| Van Heertum, RL | 1 |
| Masdeu, JC | 1 |
| Terada, H | 1 |
| Gomi, T | 1 |
| Furukawa, T | 1 |
| Murakami, S | 1 |
| Sato, S | 1 |
| Nagamoto, M | 1 |
| Sekiguchi, R | 1 |
| Kuwajima, A | 1 |
| Hiramatsu, Y | 1 |
| Sakai, T | 1 |
| Hamann, G | 1 |
| Jost, V | 1 |
| Haass, A | 1 |
| Schimrigk, K | 1 |
| Cikrit, D | 1 |
| Carter, J | 1 |
| Higashi, S | 1 |
| Nozaki, J | 1 |
| Nabi Nemati, M | 1 |
| Rogg, J | 1 |
| Rutigliano, M | 1 |
| Pentheny, S | 1 |
| Latchaw, RE | 1 |
| Bonte, FJ | 1 |
| Reisch, JS | 1 |
| Ajmani, AK | 1 |
| Weiner, MF | 1 |
| Hom, J | 1 |
| Tintner, R | 1 |
| Vorstrup, S | 1 |
| Boysen, G | 1 |
| Brun, B | 1 |
| Engell, HC | 1 |
| Clarke, C | 1 |
| Mock, BM | 1 |
| Wellman, HN | 1 |
| Schauwecker, DS | 1 |
| Witt, R | 1 |
| Sullivan, HG | 1 |
| Kingsbury, TB | 1 |
| Morgan, ME | 1 |
| Jeffcoat, RD | 1 |
| Allison, JD | 1 |
| Goode, JJ | 1 |
| McDonnell, DE | 1 |
| Gomensoro, JB | 1 |
| Regli, F | 1 |
| Waltz, AG | 1 |
| Vejjajiva, A | 1 |
| Kashemsant, U | 1 |
| Chipman, M | 1 |
| Biggers, WH | 1 |
| Gotoh, F | 2 |
| Meyer, JS | 2 |
| Takagi, Y | 1 |
| Tomita, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| C-arm Cone Beam CTA and CTP With Acetazolamide Challenge in Aneurysmal Subarachnoid Hemorrhage: Evaluating Predictability for Early Ischemia in Cerebral Vasospasm[NCT03377049] | Phase 4 | 11 participants (Actual) | Interventional | 2019-07-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Clinical neurological deterioration not attributable to other causes, mores specifically not due to re-bleeding, hydrocephalus, or metabolic changes. (NCT03377049)
Timeframe: Day 1-14 during the hospitalization
| Intervention | Participants (Count of Participants) |
|---|---|
| Acetazolamide Challenge | 2 |
Using perfusion map values, relative percent change will be calculated (NCT03377049)
Timeframe: pre and post perfusion during imaging procedure, up to an hour
| Intervention | percent change (Mean) |
|---|---|
| Acetazolamide Challenge | 19.785 |
Using perfusion map values, relative percent change will be calculated (NCT03377049)
Timeframe: pre and post perfusion during imaging procedure, up to an hour
| Intervention | percent change (Mean) |
|---|---|
| Acetazolamide Challenge | 21.659 |
The data that will be statistically compared is the pre-diamox perfusion in comparison to the post-diamox perfusion. A statistically significant change increase in CBF represents an appropriate response to Diamox. Lack of change in CBF or decrease in CBF could be suggestive of potential for developing vasospasm. (NCT03377049)
Timeframe: pre and post perfusion during imaging procedure, up to an hour
| Intervention | percent change (Mean) |
|---|---|
| Acetazolamide Challenge | 20.722 |
8 reviews available for acetazolamide and Cerebrovascular Disorders
| Article | Year |
|---|---|
Brain perfusion SPECT imaging and acetazolamide challenge in vascular cognitive impairment.
Topics: Acetazolamide; Brain; Carbonic Anhydrase Inhibitors; Cerebrovascular Disorders; Cognition Disorders; | 2012 |
CURRENT THERAPEUTIC CONCEPTS OF CEREBRAL AND MYOCARDIAL VASCULAR DISEASE.
Topics: Acetazolamide; Anticoagulants; Brain Ischemia; Cerebrovascular Disorders; Coronary Disease; Histamin | 1964 |
Acetazolamide as a vasodilatory stimulus in cerebrovascular diseases and in conditions affecting the cerebral vasculature.
Topics: Acetazolamide; Aging; Animals; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Homeosta | 2003 |
The cerebral hyperperfusion syndrome: what every family doctor should know.
Topics: Acetazolamide; Blood Flow Velocity; Cerebrovascular Circulation; Cerebrovascular Disorders; Endarter | 2004 |
Xenon/computed tomography cerebral blood flow and its use in clinical management.
Topics: Acetazolamide; Brain Injuries; Carbonic Anhydrase Inhibitors; Cerebrovascular Circulation; Cerebrova | 1996 |
[Determination of the cerebrovascular reserve capacity by using acetazolamide as well as transcranial Doppler and SPECT tests].
Topics: Acetazolamide; Blood Flow Velocity; Cerebrovascular Circulation; Cerebrovascular Disorders; Echoence | 1992 |
[The value of acetazolamide provocation combined with blood flow tests in the diagnosis of ischemic cerebrovascular diseases].
Topics: Acetazolamide; Brain Ischemia; Cerebrovascular Circulation; Cerebrovascular Disorders; Female; Human | 1992 |
Interventions and functional brain imaging.
Topics: Acetazolamide; Cerebrovascular Disorders; Humans; Tomography, Emission-Computed, Single-Photon | 1991 |
15 trials available for acetazolamide and Cerebrovascular Disorders
| Article | Year |
|---|---|
Adverse effects of intravenous acetazolamide administration for evaluation of cerebrovascular reactivity using brain perfusion single-photon emission computed tomography in patients with major cerebral artery steno-occlusive diseases.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Carbonic Anhydrase Inhib | 2011 |
A new method for measuring dynamic change of tracer distribution using dynamic single photon emission tomography with a slip-ring rotational gamma camera.
Topics: Acetazolamide; Aged; Brain; Cerebrovascular Disorders; Cysteine; Feasibility Studies; Female; Gamma | 2002 |
Validation of the dual-table autoradiographic method to quantify two sequential rCBFs in a single SPET session with N-isopropyl-[123I] p-iodoamphetamine.
Topics: Acetazolamide; Algorithms; Autoradiography; Brain; Cerebrovascular Circulation; Cerebrovascular Diso | 2003 |
Differences in vasodilatory capacity and changes in cerebral blood flow induced by acetazolamide in patients with cerebrovascular disease.
Topics: Acetazolamide; Adult; Aged; Arterial Occlusive Diseases; Blood Flow Velocity; Brain; Cerebral Arteri | 2003 |
Relationship between vasodilatation and cerebral blood flow increase in impaired hemodynamics: a PET study with the acetazolamide test in cerebrovascular disease.
Topics: Acetazolamide; Aged; Arterial Occlusive Diseases; Brain; Cerebral Arterial Diseases; Cerebrovascular | 2003 |
Effects of tissue heterogeneity on cerebral vascular response to acetazolamide stress measured by an I-123-IMP autoradiographic method with single-photon emission computed tomography.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Artifacts; Autoradiography; Cerebrovascular Circulati | 2005 |
Quantitative evaluation of cerebrovascular reactivity in brain tissue by a refill kinetic method of transcranial ultrasonic perfusion imaging: a comparison with Doppler sonography.
Topics: Acetazolamide; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Contrast Media; Female | 2005 |
[SPECT evaluation of cerebral perfusion reserve in patients with occlusive cerebrovascular diseases: evaluation with acetazolamide test and crossed cerebellar diaschisis].
Topics: Acetazolamide; Adult; Aged; Brain; Cerebellar Diseases; Cerebrovascular Circulation; Cerebrovascular | 1995 |
Evaluation of cerebral vasoreactivity by SPECT and transcranial Doppler sonography using the acetazolamide test.
Topics: Acetazolamide; Adult; Aged; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Echoencep | 1994 |
[Usefulness of change ratio map in 99mTc-HMPAO SPECT with acetazolamide enhancement].
Topics: Acetazolamide; Aged; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Disease; | 1996 |
[Acetazolamide reactivity on SPECT correlates with PET parameters].
Topics: Acetazolamide; Aged; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Female; Humans; | 1995 |
[Cerebrovascular reactivity in insulin dependent diabetes mellitus studied by an acetazolamide test].
Topics: Acetazolamide; Adult; Blood Flow Velocity; Cerebrovascular Circulation; Cerebrovascular Disorders; D | 1996 |
[Noninvasive quantitative measurements of regional cerebral blood flow using technetium-99m-L, L-ECD SPECT activated with acetazolamide].
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Brain; Cerebrovascular Circulation; Cerebrovascular D | 1996 |
[Assessment of cerebrovascular reactivity in patients with symptomatic and asymptomatic atherosclerotic carotid artery lesions].
Topics: Acetazolamide; Arteriosclerosis; Blood Flow Velocity; Carotid Stenosis; Cerebrovascular Circulation; | 1998 |
Usefulness of a three-dimensional stereotaxic ROI template on anatomically standardised 99mTc-ECD SPET.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Cerebrovascular Circulation; Cerebrovascular Disorder | 2002 |
96 other studies available for acetazolamide and Cerebrovascular Disorders
| Article | Year |
|---|---|
Safety and efficacy of staged angioplasty for patients at risk of hyperperfusion syndrome: a single-center retrospective study.
Topics: Acetazolamide; Aged; Aged, 80 and over; Angioplasty, Balloon; Carotid Stenosis; Cerebral Angiography | 2020 |
The regional pattern of abnormal cerebrovascular reactivity in HIV-infected, virally suppressed women.
Topics: Acetazolamide; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Basal Ganglia; Cerebral Arter | 2020 |
Assessment of cerebrovascular reserve with N-isopropyl-p-[123I]-iodoamphetamine time series analysis in patients with cerebrovascular disease.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Anterior Cerebral Artery; Brain Ischemia; Cerebral Re | 2021 |
The Brain Thermal Response as a Potential Neuroimaging Biomarker of Cerebrovascular Impairment.
Topics: Acetazolamide; Adult; Aged; Biomarkers; Body Temperature; Brain; Carbonic Anhydrase Inhibitors; Cere | 2017 |
Objective evaluation of cerebrovascular reactivity for acetazolamide predicts cerebral hyperperfusion after carotid artery stenting: Comparison with region of interest methods.
Topics: Acetazolamide; Brain; Carotid Stenosis; Cerebrovascular Disorders; Female; Humans; Male; Postoperati | 2018 |
Intracerebral steal phenomenon in symptomatic carotid artery disease.
Topics: Acetazolamide; Aged; Carotid Stenosis; Cerebrovascular Circulation; Cerebrovascular Disorders; Circl | 2019 |
Neuronal activation induced BOLD and CBF responses upon acetazolamide administration in patients with steno-occlusive artery disease.
Topics: Acetazolamide; Aged; Arterial Occlusive Diseases; Brain; Carbonic Anhydrase Inhibitors; Cerebrovascu | 2015 |
Arterial Spin Labeling Perfusion Magnetic Resonance Image with Dual Postlabeling Delay: A Correlative Study with Acetazolamide Loading (123)I-Iodoamphetamine Single-Photon Emission Computed Tomography.
Topics: Acetazolamide; Aged; Aged, 80 and over; Carotid Artery, Internal; Carotid Stenosis; Cerebral Arterie | 2016 |
Near infrared spectroscopy--investigations in neurovascular diseases.
Topics: Acetazolamide; Adult; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Cerebrum; Clust | 2015 |
Prediction of cerebral hyperperfusion syndrome after carotid artery stenting by CT perfusion imaging with acetazolamide challenge.
Topics: Acetazolamide; Aged; Aged, 80 and over; Carotid Arteries; Cerebrovascular Disorders; Computed Tomogr | 2016 |
Preoperative prediction of cerebral hyperperfusion after carotid endarterectomy using middle cerebral artery signal intensity in 1.5-tesla magnetic resonance angiography followed by cerebrovascular reactivity to acetazolamide using brain perfusion single-
Topics: Acetazolamide; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Cerebrovascular Circulation; | 2016 |
The Effects of Acetazolamide on the Evaluation of Cerebral Hemodynamics and Functional Connectivity Using Blood Oxygen Level-Dependent MR Imaging in Patients with Chronic Steno-Occlusive Disease of the Anterior Circulation.
Topics: Acetazolamide; Adult; Aged; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Female; H | 2017 |
Acetazolamide-augmented dynamic BOLD (aczBOLD) imaging for assessing cerebrovascular reactivity in chronic steno-occlusive disease of the anterior circulation: An initial experience.
Topics: Acetazolamide; Adult; Aged; Arterial Occlusive Diseases; Carbonic Anhydrase Inhibitors; Cerebrovascu | 2017 |
Effect of perindopril on vasoreactivity in patients with hypertensive chronic cerebrovascular disease. A comparative analysis of different brain structures.
Topics: Acetazolamide; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cerebrovascu | 2008 |
Staged angioplasty for carotid artery stenosis to prevent postoperative hyperperfusion.
Topics: Acetazolamide; Aged; Angioplasty, Balloon; Blood Pressure; Carotid Stenosis; Cerebrovascular Disorde | 2009 |
Symptomatic carotid artery stenosis: impairment of cerebral autoregulation measured at the brain tissue level with arterial spin-labeling MR imaging.
Topics: Acetazolamide; Aged; Blood Flow Velocity; Carbonic Anhydrase Inhibitors; Carotid Stenosis; Case-Cont | 2010 |
Multicenter evaluation of a standardized protocol for rest and acetazolamide cerebral blood flow assessment using a quantitative SPECT reconstruction program and split-dose 123I-iodoamphetamine.
Topics: Acetazolamide; Amphetamines; Asia; Australia; Cerebrovascular Circulation; Cerebrovascular Disorders | 2010 |
Quantitative assessment of cerebral hemodynamics using single photon emission computed tomography with venous blood sampling.
Topics: Acetazolamide; Adult; Aged; Arterial Occlusive Diseases; Brain; Cerebrovascular Circulation; Cerebro | 2013 |
VASODILATORS IN CEREBRAL VASCULAR INSUFFICIENCY.
Topics: Acetazolamide; Blood Flow Velocity; Brain Ischemia; Carbon Dioxide; Cerebrovascular Circulation; Cer | 1963 |
[Fully automated ROI analysis software for the brain; 3DSRT].
Topics: Acetazolamide; Adolescent; Aged; Aged, 80 and over; Cerebrovascular Circulation; Cerebrovascular Dis | 2003 |
[Development of quantification analysis software for measuring regional cerebral blood flow by the modified split-dose method with (123)I-IMP before and after acetazolamide loading].
Topics: Acetazolamide; Adult; Aged; Cerebrovascular Circulation; Cerebrovascular Disorders; Female; Humans; | 2003 |
Exfoliative glaucoma and primary open-angle glaucoma: associations with death causes and comorbidity.
Topics: Acetazolamide; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Cause of Death; Cerebrovascul | 2004 |
Factors predictive of cerebral hyperperfusion after carotid angioplasty and stent placement.
Topics: Acetazolamide; Aged; Aged, 80 and over; Amphetamines; Angioplasty, Balloon; Carotid Stenosis; Cerebr | 2004 |
[Cerebral perfusion in patients with metabolic syndrome].
Topics: Acetazolamide; Adult; Brain; Carbonic Anhydrase Inhibitors; Cerebrovascular Circulation; Cerebrovasc | 2005 |
Relationship between cerebral circulatory reserve and oxygen extraction fraction in patients with major cerebral artery occlusive disease: a positron emission tomography study.
Topics: Acetazolamide; Adult; Aged; Brain; Cerebral Arterial Diseases; Cerebrovascular Circulation; Cerebrov | 2006 |
Cerebral vasomotor reactivity in Parkinson's disease, multiple system atrophy and pure autonomic failure.
Topics: Acetazolamide; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Brain; Cerebrovascular Ci | 2006 |
Can the detection of misery perfusion in chronic cerebrovascular disease be based on reductions in baseline CBF and vasoreactivity?
Topics: Acetazolamide; Adult; Aged; Anticonvulsants; Cerebrovascular Circulation; Cerebrovascular Disorders; | 2007 |
Dynamic CT perfusion imaging with acetazolamide challenge for evaluation of patients with unilateral cerebrovascular steno-occlusive disease.
Topics: Acetazolamide; Aged; Aged, 80 and over; Basal Ganglia; Blood Circulation; Blood Flow Velocity; Blood | 2006 |
Granulocyte-macrophage colony-stimulating factor-induced vessel growth restores cerebral blood supply after bilateral carotid artery occlusion.
Topics: Acetazolamide; Angiogenic Proteins; Animals; Antipyrine; Capillaries; Carotid Stenosis; Cerebral Art | 2007 |
Perfusion-CT assessment of the cerebrovascular reserve: a revisit to the acetazolamide challenges.
Topics: Acetazolamide; Adult; Aged; Anticonvulsants; Cerebrovascular Circulation; Cerebrovascular Disorders; | 2008 |
Time dependency of the acetazolamide effect on cerebral hemodynamics in patients with chronic occlusive cerebral arteries. Early steal phenomenon demonstrated by [15O]H2O positron emission tomography.
Topics: Acetazolamide; Aged; Arterial Occlusive Diseases; Blood Pressure; Brain Ischemia; Carotid Artery, In | 1995 |
Evaluation of the acetazolamide test. Vasoreactivity and cerebral blood volume.
Topics: Acetazolamide; Adult; Analysis of Variance; Blood Pressure; Blood Volume; Cerebral Arteries; Cerebro | 1995 |
An approach to cerebral vasodilatory capacity in unilateral and bilateral cerebrovascular diseases using radiolabeled human serum albumin.
Topics: Acetazolamide; Adolescent; Adult; Aged; Carotid Stenosis; Cerebral Infarction; Cerebrovascular Circu | 1995 |
Evaluation of a double-injection method for sequential measurement of cerebral blood flow with iodine-123-iodoamphetamine.
Topics: Acetazolamide; Amphetamines; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Humans; | 1995 |
Compromised cerebral blood flow reactivity is a predictor of stroke in patients with symptomatic carotid artery occlusive disease.
Topics: Acetazolamide; Adult; Aged; Carotid Stenosis; Cerebral Arteries; Cerebral Infarction; Cerebrovascula | 1995 |
Normal values of cerebrovascular reserve capacity after stimulation with acetazolamide measured by xenon 133 single-photon emission CT.
Topics: Acetazolamide; Adult; Aged; Blood Flow Velocity; Brain; Cerebrovascular Disorders; Dose-Response Rel | 1994 |
Correlation of xenon-enhanced computed tomography-defined cerebral blood flow reactivity and collateral flow patterns.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Brain; Carotid Artery Diseases; Cerebral Angiography; | 1994 |
Diagnostic applications of simultaneously acquired dual-isotope single-photon emission CT scans.
Topics: Acetazolamide; Adolescent; Adult; Aged; Amphetamines; Brain; Brain Diseases; Cerebrovascular Disorde | 1994 |
[Linealization correction for acetazolamide (Diamox) 99mTc-HMPAO SPECT image--a comparative study with PET].
Topics: Acetazolamide; Cerebrovascular Circulation; Cerebrovascular Disorders; Humans; Image Interpretation, | 1994 |
[The relationship of periventricular hyperintensity with cerebral blood flow and cerebrovascular reserve capacity in asymptomatic individuals].
Topics: Acetazolamide; Aged; Aged, 80 and over; Cerebral Ventricles; Cerebrovascular Circulation; Cerebrovas | 1993 |
Assessment of postischemic reperfusion and diamox activation test in stroke using 99mTc-ECD SPECT.
Topics: Acetazolamide; Adult; Aged; Brain Ischemia; Cerebrovascular Disorders; Cysteine; Female; Humans; Mal | 1994 |
Cerebral versus myocardial stress perfusion imaging: role of pharmacological intervention in the diagnostic assessment of flow reserve.
Topics: Acetazolamide; Arterial Occlusive Diseases; Carbon Dioxide; Cerebrovascular Circulation; Cerebrovasc | 1994 |
[Stable xenon computed tomography. Methodology and clinical application].
Topics: Acetazolamide; Administration, Inhalation; Cerebrovascular Circulation; Cerebrovascular Disorders; H | 1993 |
Increased stroke risk predicted by compromised cerebral blood flow reactivity.
Topics: Acetazolamide; Aged; Carotid Stenosis; Cerebrovascular Circulation; Cerebrovascular Disorders; Femal | 1993 |
Contribution of arterial blood pressure to the clinical expression of lacunar infarction.
Topics: Acetazolamide; Age Factors; Aged; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Brain Ische | 1996 |
[Noninvasive quantification of cerebral blood volume and blood flow with dynamic MR tomography. Studies of probands and patients with cerebrovascular insufficiency].
Topics: Acetazolamide; Blood Flow Velocity; Blood Volume; Brain; Cerebral Cortex; Cerebrovascular Disorders; | 1995 |
Comparison of measurement between Xe/CT CBF and PET in cerebrovascular disease and brain tumor.
Topics: Acetazolamide; Adult; Aged; Artifacts; Blood Flow Velocity; Brain; Brain Neoplasms; Cerebrovascular | 1996 |
Effect of Xenon.
Topics: Acetazolamide; Adult; Aged; Cerebrovascular Disorders; Contrast Media; Female; Humans; Male; Middle | 1996 |
Phase-contrast magnetic resonance angiography for the determination of cerebrovascular reserve.
Topics: Acetazolamide; Adult; Arterioles; Blood Flow Velocity; Blood Pressure; Carbonic Anhydrase Inhibitors | 1996 |
Susceptibility-weighted MR for evaluation of vasodilatory capacity with acetazolamide challenge.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Blood Flow Velocity; Brain; Brain Ischemia; Carbonic | 1996 |
Is image subtraction necessary in the clinical interpretation of single-day split-dose stress cerebral perfusion single-photon emission tomography using technetium-99m compounds?
Topics: Acetazolamide; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Female; Humans; Image | 1996 |
Is impaired cerebral vasomotor reactivity a predictive factor of stroke in asymptomatic patients?
Topics: Acetazolamide; Aged; Brain Ischemia; Carotid Stenosis; Cerebrovascular Disorders; Female; Humans; Ma | 1996 |
One-day protocol for cerebral perfusion reserve with acetazolamide.
Topics: Acetazolamide; Adult; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Cysteine; Femal | 1996 |
Vasoreactive effect of acetazolamide as a function of time with sequential PET 15O-water measurement.
Topics: Acetazolamide; Aged; Carbonic Anhydrase Inhibitors; Cerebrovascular Circulation; Cerebrovascular Dis | 1996 |
[Regional cerebral blood flow measurements at pre- and post-Diamox test using split dose 99mTc-ECD SPECT: comparison with 133Xe inhalation method and linearization correction].
Topics: Acetazolamide; Administration, Inhalation; Adult; Aged; Brain; Cerebrovascular Circulation; Cerebrov | 1997 |
Comparison of vasodilatory effect of carbon dioxide inhalation and intravenous acetazolamide on brain vasculature using positron emission tomography.
Topics: Acetazolamide; Administration, Inhalation; Aged; Carbon Dioxide; Cerebrovascular Circulation; Cerebr | 1997 |
Acetazolamide challenge and technetium-99m-ECD versus iodine-123-IMP SPECT in chronic occlusive cerebrovascular disease.
Topics: Acetazolamide; Aged; Aged, 80 and over; Amphetamines; Cerebrovascular Circulation; Cerebrovascular D | 1997 |
[Quantitative measurements of regional cerebral blood flow using technetium-99m-L,L-ECD SPECT activated with acetazolamide: fundamental study of measurement's accuracy, comparison with 123I-IMP ARG method].
Topics: Acetazolamide; Aged; Aged, 80 and over; Amphetamines; Brain; Cerebrovascular Circulation; Cerebrovas | 1997 |
Effect of acetazolamide reactivity on [corrected] long-term outcome in patients with major cerebral artery occlusive diseases.
Topics: Acetazolamide; Adult; Aged; Arterial Occlusive Diseases; Blood Pressure; Cerebral Arteries; Cerebrov | 1998 |
Combined thallium-201 myocardial with technetium-99m-HMPAO brain SPECT: myocardial ischemia induced by acetazolamide in severe coronary artery disease.
Topics: Acetazolamide; Aged; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Coronary Artery | 1998 |
[Quantification of regional cerebral blood flow at the control state and loaded with diamox using split-dose 99mTc-ECD SPECT and venous blood samples].
Topics: Acetazolamide; Adult; Aged; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Cysteine; | 1998 |
Qualitative versus quantitative assessment of cerebrovascular reserves.
Topics: Acetazolamide; Carotid Stenosis; Cerebrovascular Circulation; Cerebrovascular Disorders; Collateral | 1998 |
PET evaluation of cerebral hemodynamics in occlusive cerebrovascular disease pre- and postsurgery.
Topics: Acetazolamide; Arterial Occlusive Diseases; Brain; Cerebral Revascularization; Cerebrovascular Circu | 1998 |
Posthyperventilatory steal response in chronic cerebral hemodynamic stress: a positron emission tomography study.
Topics: Acetazolamide; Administration, Inhalation; Adult; Aged; Blood Volume; Brain; Brain Ischemia; Carbon | 1998 |
Use of 123I-IMP brain SPET to predict outcome following STA-MCA bypass surgery: cerebral blood flow but not vasoreactivity is a predictive parameter.
Topics: Acetazolamide; Adolescent; Adult; Aged; Amphetamines; Brain; Cerebral Revascularization; Cerebrovasc | 1998 |
Simplified quantitative determination of cerebral perfusion reserve with H2(15)O PET and acetazolamide.
Topics: Acetazolamide; Adolescent; Adult; Aged; Cerebrovascular Circulation; Cerebrovascular Disorders; Fema | 2000 |
The threshold of acetazolamide vasoreactivity as an indicator of maximum cerebral blood volume.
Topics: Acetazolamide; Adult; Blood Volume; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; C | 2000 |
Guidelines for brain radionuclide imaging. Perfusion single photon computed tomography (SPECT) using Tc-99m radiopharmaceuticals and brain metabolism positron emission tomography (PET) using F-18 fluorodeoxyglucose. The Belgian Society for Nuclear Medicin
Topics: Acetazolamide; Adult; Brain; Brain Death; Cerebrovascular Disorders; Child; Craniocerebral Trauma; D | 2001 |
Acute therapeutic modalities for experimental vasogenic edema.
Topics: Acetazolamide; Acute Disease; Animals; Brain Edema; Cerebrovascular Disorders; Cold Temperature; Dex | 1979 |
Dual-isotope brain SPECT imaging with technetium-99m and iodine-123: clinical validation using xenon-133 SPECT.
Topics: Acetazolamide; Adult; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Female; Humans; | 1992 |
99mTc-HMPAO-SPECT with acetazolamide challenge to detect hemodynamic compromise in occlusive cerebrovascular disease.
Topics: Acetazolamide; Adult; Aged; Arterial Occlusive Diseases; Cerebral Angiography; Cerebrovascular Disor | 1992 |
[MR angiography enhanced by sodium acetazolamide].
Topics: Acetazolamide; Aged; Aged, 80 and over; Brain; Carbonic Anhydrase Inhibitors; Cerebrovascular Circul | 1992 |
Acetazolamide enhanced single photon emission computed tomography (SPECT) evaluation of cerebral perfusion before and after carotid endarterectomy.
Topics: Acetazolamide; Aged; Aged, 80 and over; Blindness; Carotid Stenosis; Cerebrovascular Circulation; Ce | 1992 |
Acetazolamide effect on vascular response in areas with diaschisis as measured by Tc-99m HMPAO brain SPECT.
Topics: Acetazolamide; Adult; Aged; Cerebellar Diseases; Cerebrovascular Disorders; Female; Humans; Male; Mi | 1992 |
Effects of diuretics on stroke development in Kyoto-Wistar stroke-prone spontaneously hypertensive rats.
Topics: Acetazolamide; Amiloride; Animals; Cerebrovascular Disorders; Chlorothiazide; Diet; Diuretics; Furos | 1991 |
Hemodynamic evaluation in patients with superficial temporal artery-middle cerebral artery anastomosis--stable xenon CT-CBF study and acetazolamide.
Topics: Acetazolamide; Aged; Anastomosis, Surgical; Cerebral Arteries; Cerebrovascular Circulation; Cerebrov | 1990 |
Evaluation of cerebral vasomotor reactivity by various vasodilating stimuli: comparison of CO2 to acetazolamide.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Carbon Dioxide; Carotid | 1992 |
A comparison of transcranial Doppler and cerebral blood flow studies to assess cerebral vasoreactivity.
Topics: Acetazolamide; Adolescent; Adult; Aged; Blood Flow Velocity; Cerebral Arteries; Cerebrovascular Circ | 1992 |
Carotid artery disease: evaluation with acetazolamide-enhanced Tc-99m HMPAO SPECT.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Carotid Artery Diseases; | 1992 |
CBF side-to-side asymmetries in stenosis-occlusion of internal carotid artery. Relevance of CT findings and collateral supply.
Topics: Acetazolamide; Adult; Aged; Carotid Artery, Internal; Carotid Stenosis; Cerebral Infarction; Cerebro | 1991 |
[Cerebral perfusion reserve SPECT imaging before and during acetazolamide test using consecutive 99mTc-HMPAO SPECT].
Topics: Acetazolamide; Adolescent; Adult; Aged; Brain; Cerebrovascular Disorders; Child; Humans; Middle Aged | 1991 |
Acetazolamide test evaluating cerebral autoregulation.
Topics: Acetazolamide; Cerebral Arteries; Cerebral Cortex; Cerebrovascular Disorders; Homeostasis; Humans; V | 1991 |
Increased brain retention of Tc-99m HMPAO following acetazolamide administration.
Topics: Acetazolamide; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Humans; Male; Middle A | 1991 |
SPECT evaluation of brain perfusion reserve by the acetazolamide test using Tc-99m HMPAO.
Topics: Acetazolamide; Aged; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Evaluation Studi | 1991 |
[Non-invasive measurement of cerebrovascular circulation using xenon(s) computerized tomography. A review].
Topics: Acetazolamide; Adult; Brain Ischemia; Brain Neoplasms; Carotid Artery Diseases; Carotid Artery, Inte | 1990 |
The acetazolamide challenge: imaging techniques designed to evaluate cerebral blood flow reserve.
Topics: Acetazolamide; Adult; Aged; Cerebrovascular Circulation; Cerebrovascular Disorders; Female; Humans; | 1989 |
The effect of acetazolamide on regional cerebral blood flow in patients with Alzheimer's disease or stroke as measured by single-photon emission computed tomography.
Topics: Acetazolamide; Aged; Aged, 80 and over; Alzheimer Disease; Cerebrovascular Circulation; Cerebrovascu | 1989 |
Evaluation of the regional cerebral vasodilatory capacity before carotid endarterectomy by the acetazolamide test.
Topics: Acetazolamide; Adult; Aged; Brain; Carotid Artery Diseases; Cerebrovascular Disorders; Endarterectom | 1987 |
High altitude cerebral oedema.
Topics: Acetazolamide; Adolescent; Altitude Sickness; Brain Edema; Cerebrovascular Disorders; Female; Humans | 1988 |
Acetazolamide enhancement of HIPDM brain flow distribution imaging.
Topics: Acetazolamide; Cerebrovascular Circulation; Cerebrovascular Disorders; Humans; Iodobenzenes; Tomogra | 1986 |
The rCBF response to Diamox in normal subjects and cerebrovascular disease patients.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Aging; Cerebrovascular Circulation; Cerebrovascular D | 1987 |
[Use of hydergine in acute ischemic pathology of the brain].
Topics: Acetazolamide; Adult; Aged; Aminophylline; Arrhythmias, Cardiac; Carbon Dioxide; Cerebrovascular Cir | 1967 |
Effects of hyperventilation, hypocapnia, and acetazolamide on experimental cerebral ischemia and infarction.
Topics: Acetazolamide; Animals; Brain Edema; Carbon Dioxide; Cats; Cerebrovascular Circulation; Cerebrovascu | 1972 |
Combined effect of carbon dioxide and acetazolamide on cerebral blood flow in occlusive cerebral vascular diseases.
Topics: Acetazolamide; Blood Flow Velocity; Carbon Dioxide; Cerebrovascular Circulation; Cerebrovascular Dis | 1971 |
Cerebral venous and arterial blood gases during Cheyne-Stokes respiration.
Topics: Acetazolamide; Adult; Aged; Blood Gas Analysis; Carbon Dioxide; Cerebrovascular Disorders; Cheyne-St | 1969 |
Carbonic anhydrase inhibition and cerebral venous blood gases and ions in man. Demonstration of increased oxygen availability to ischemic brain.
Topics: Acetazolamide; Aged; Blood; Blood Gas Analysis; Brain; Carbon Dioxide; Cerebrovascular Circulation; | 1966 |